BMJ  2007;334:1159-1162 (2 June), doi:10.1136/bmj.39192.488125.BE

Practice

Recent advances

Skin biopsy: a new tool for diagnosing peripheral neuropathy

Giuseppe Lauria, consultant, Raffaella Lombardi, neurobiologist

Neuromuscular Diseases Unit, National Neurological Institute "Carlo Besta", 20133, Milan, Italy

Correspondence to: G Lauria glauria@istituto-besta.it

The first 150 words of the full text of this article appear below.

Introduction

The prevalence of peripheral neuropathy is about 2% in the general population, but it rises to 12% and 17% in people with one or two recognised risk factors.1 Diabetes is one such risk factor and the most common cause of this disorder—about half of patients who have had diabetes for 25 years have peripheral neuropathy. The early symptoms of diabetic neuropathy and other peripheral neuropathies are due to degeneration of small somatic nerve fibres, which may remain the only nerves involved.2 However, "small fibre neuropathy" may not be detected by traditional physical, neurophysiological, and neuropathological tests. In the past decade, skin biopsy has become a popular method for investigating small nerve fibres.3 It allows general practitioners and non-specialists—such as diabetologists and specialists in orthopaedics—to diagnose neuropathy (thereby avoiding delayed or incorrect diagnosis), to investigate its aetiology, and to focus treatment, in particular for neuropathic pain.

Sources and selection criteria

We searched the Medline database . . . [Full text of this article]

What are the clinical features of small fibre neuropathy?

What are the limitations of diagnostic tests for peripheral neuropathy?

What can skin biopsy show that other methods can't?

What are the other clinical uses of skin biopsy?

Demonstrating subclinical peripheral neuropathy
Demonstrating autonomic neuropathy
Monitoring neuropathy

How is a skin biopsy carried out?

Additional educational resources

How can I measure the density of intraepidermal nerve fibres?

What can you see in a skin biopsy?

Unmyelinated fibres
Myelinated fibres
Autonomic nerve fibres

What are the limitations of skin biopsy?

Summary points

Conclusion

Ongoing research

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

Watch out for digital nerves
Bo Povlsen
BMJ 2007 334: 1236. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

  • Boulton, A. J.M. (2007). Whither Clinical Research in Diabetic Sensorimotor Peripheral Neuropathy?: Problems of end point selection for clinical trials. Diabetes Care 30: 2752-2753 [Full text]  
  • Wallace, V. C. J., Blackbeard, J., Segerdahl, A. R., Hasnie, F., Pheby, T., McMahon, S. B., Rice, A. S. C. (2007). Characterization of rodent models of HIV-gp120 and anti-retroviral-associated neuropathic pain. Brain 130: 2688-2702 [Abstract] [Full text]  
  • Povlsen, B. (2007). Watch out for digital nerves. BMJ 334: 1236-1236 [Full text]  

Rapid Responses:

Read all Rapid Responses

Skin biopsy: Watch out for the digital nerves.
Bo Povlsen
bmj.com, 7 Jun 2007 [Full text]
Skin biopsy: Watch out for the digital nerves.
Giuseppe Lauria
bmj.com, 11 Jun 2007 [Full text]
Evidence-based demyelination
GEORGE Y CALDWELL, et al.
bmj.com, 19 Jun 2007 [Full text]



Access all current jobs at BMJ Group
Whats new online at Student 

BMJ
Listen to the latest 

BMJ Interview